Xeroderma Pigmentosum: Symptoms, Causes, and Treatment

What is Xeroderma Pigmentosum?

Xeroderma Pigmentosum (XP) is a rare genetic disorder characterized by an extreme sensitivity to ultraviolet (UV) radiation from sunlight. This condition significantly increases the risk of developing skin cancer and other sun-induced skin damage. Individuals with XP have a defective ability to repair DNA damage caused by UV light, leading to premature skin aging, frequent sunburns, and a high incidence of skin cancers, including basal cell carcinoma, squamous cell carcinoma, and melanoma.

XP affects approximately 1 in 1 million people worldwide, though it is more common in certain populations, such as in Japan, where the incidence is about 1 in 20,000 (NIH - National Institute of Neurological Disorders and Stroke). The condition is typically diagnosed in early childhood, often before the age of 2, when parents notice severe sunburns or freckling after minimal sun exposure.

Common Causes

Xeroderma Pigmentosum is primarily caused by mutations in genes responsible for DNA repair. These mutations are inherited in an autosomal recessive manner, meaning a child must inherit a defective gene from both parents to develop the condition. Below are the key genetic and environmental factors associated with XP:

• Mutations in the XPA gene: This gene provides instructions for producing a protein involved in the nucleotide excision repair (NER) pathway, which fixes DNA damage caused by UV radiation.
• Mutations in the XPC gene: Another critical gene in the NER pathway; mutations here are among the most common causes of XP.
• Mutations in other NER genes: Genes such as XPB, XPD, XPE, XPF, and XPG can also be mutated, each playing a role in different steps of the DNA repair process.
• Autosomal recessive inheritance: Both parents must carry a defective gene, even if they do not show symptoms themselves.
• Consanguinity: XP is more common in children born to parents who are closely related (e.g., cousins), increasing the likelihood of inheriting two defective genes.
• UV radiation exposure: While not a cause of XP itself, UV exposure is the primary environmental trigger that leads to the symptoms and complications of the condition.
• Defective DNA repair mechanisms: The underlying issue in XP is the body's inability to repair DNA damage, leading to the accumulation of mutations.
• De novo mutations: In rare cases, XP can occur due to new mutations that are not inherited from either parent.

Sources: NIH - Genetics Home Reference, Mayo Clinic, Cleveland Clinic

Associated Symptoms

Xeroderma Pigmentosum primarily affects the skin, eyes, and sometimes the nervous system. Symptoms often appear in early childhood and worsen with continued sun exposure. Common symptoms include:

• Severe sunburns: Even minimal sun exposure can cause blistering sunburns, often appearing within minutes of exposure.
• Freckling in sun-exposed areas: Unusual freckling or dark spots (solar lentigines) may develop on the face, arms, and other areas exposed to sunlight.
• Dry skin (xeroderma): The skin may become extremely dry, rough, and scaly, particularly in sun-exposed areas.
• Premature skin aging: The skin may appear thin, wrinkled, or leathery, resembling the skin of someone much older.
• Telangiectasias: Small, dilated blood vessels near the surface of the skin, often appearing as red spider-like marks.
• Actinic keratoses: Rough, scaly patches on the skin that can develop into skin cancer if untreated.
• Eye problems: Photophobia (extreme sensitivity to light), redness, irritation, clouding of the cornea, and an increased risk of eye cancers (e.g., ocular melanoma).
• Neurological symptoms (in some cases): Approximately 20-30% of individuals with XP may develop neurological issues, such as intellectual disability, hearing loss, poor coordination, or progressive neurodegeneration (NIH - National Institute of Neurological Disorders and Stroke).
• High risk of skin cancers: Basal cell carcinoma, squamous cell carcinoma, and melanoma often develop in childhood or adolescence, decades earlier than in the general population.

When to See a Doctor

If you or your child exhibit any of the following signs, it is critical to seek medical evaluation promptly:

• Severe sunburns after minimal sun exposure, especially in infancy or early childhood.
• Development of freckles or dark spots on the skin before the age of 2.
• Unusual dryness, scaling, or thickening of the skin in sun-exposed areas.
• Redness, irritation, or cloudiness in the eyes, particularly after sun exposure.
• Any new or changing skin lesions, such as growths, sores that do not heal, or moles that change in size, shape, or color.
• Signs of neurological issues, such as delayed development, hearing loss, or difficulty with coordination.

Early diagnosis and intervention are crucial for managing XP and reducing the risk of complications like skin cancer. If XP is suspected, a referral to a dermatologist or geneticist is recommended.

Diagnosis

Diagnosing Xeroderma Pigmentosum involves a combination of clinical evaluation, genetic testing, and specialized laboratory tests. Here’s how doctors typically approach diagnosis:

Clinical Evaluation

• A thorough medical history, including family history of XP or skin cancers.
• Physical examination focusing on the skin, eyes, and neurological function.
• Assessment of sun exposure history and the presence of sunburns, freckling, or skin changes.

Genetic Testing

• Genetic testing is the gold standard for diagnosing XP. A blood sample is analyzed to identify mutations in the genes associated with XP (e.g., XPA, XPC, XPD, etc.).
• Prenatal testing may be offered to families with a history of XP to determine if the fetus has inherited the condition.

Laboratory Tests

• UV sensitivity testing: Skin cells (fibroblasts) from the patient are exposed to UV radiation in a lab to measure their ability to repair DNA damage. Cells from XP patients show significantly reduced repair capacity.
• Unscheduled DNA synthesis (UDS) test: This test measures the ability of cells to repair DNA damage. XP cells typically show very low levels of UDS after UV exposure.

Other Tests

• Skin biopsies may be performed to examine suspicious lesions for signs of precancerous changes or cancer.
• Eye examinations by an ophthalmologist to assess for UV-related damage, such as corneal clouding or tumors.
• Neurological evaluations if symptoms suggest involvement of the nervous system.

Sources: Mayo Clinic, NIH - Genetic and Rare Diseases Information Center

Treatment Options

While there is no cure for Xeroderma Pigmentosum, treatment focuses on managing symptoms, preventing complications, and aggressively protecting against UV radiation. A multidisciplinary approach involving dermatologists, ophthalmologists, oncologists, and geneticists is often necessary.

Medical Treatments

• Topical treatments:
  • Emollients and moisturizers to manage dry skin.
  • Topical corticosteroids for inflammatory skin conditions.
  • Fluorouracil (5-FU) cream or imiquimod for actinic keratoses or early skin cancers.
• Surgical treatments:
  • Excision or Mohs surgery to remove skin cancers.
  • Cryotherapy (freezing) or laser therapy for precancerous lesions.
• Ophthalmic treatments:
  • Artificial tears or lubricating eye drops for dryness and irritation.
  • Surgical removal of eye tumors or corneal transplants in severe cases.
• Neurological management:
  • Physical, occupational, or speech therapy for individuals with neurological symptoms.
  • Anticonvulsant medications if seizures are present.
• Regular screenings:
  • Frequent skin examinations (every 3-6 months) to monitor for skin cancers.
  • Annual eye examinations to detect and treat UV-related eye damage.
  • Neurological assessments if symptoms are present.

Home and Lifestyle Management

• Strict UV avoidance:
  • Avoid all direct sunlight. Stay indoors during peak UV hours (10 AM to 4 PM).
  • Use UV-protective window films on home and car windows to block UVA and UVB rays.
• Protective clothing:
  • Wear long-sleeved shirts, long pants, and wide-brimmed hats made from UV-protective fabric.
  • Use gloves and UV-blocking sunglasses with side shields.
• Sunscreen use:
  • Apply broad-spectrum sunscreen with an SPF of 50 or higher to all exposed skin, even on cloudy days.
  • Reapply sunscreen every 2 hours or immediately after swimming or sweating.
• Artificial lighting precautions:
  • Avoid fluorescent and halogen lights, which can emit UV radiation. Use LED or incandescent bulbs instead.
• Vitamin D supplementation:
  • Since sun avoidance limits natural vitamin D production, supplements may be necessary to prevent deficiency.

Sources: American Academy of Dermatology, XP Family Support Group, NIH

Prevention Tips

While Xeroderma Pigmentosum itself cannot be prevented due to its genetic nature, the complications associated with the condition—such as skin cancer and eye damage—can be significantly reduced with diligent preventive measures. Here are key strategies:

• Genetic counseling: Families with a history of XP should seek genetic counseling before planning a pregnancy to understand the risks and options, such as prenatal testing or preimplantation genetic diagnosis (PGD).
• Newborn screening: If there is a family history of XP, early genetic testing for newborns can lead to prompt diagnosis and intervention.
• UV protection from birth: For infants diagnosed with XP, UV protection should begin immediately. Use protective clothing, sunscreen (for babies over 6 months), and UV-blocking window covers.
• Education and awareness: Teach children with XP about the importance of sun avoidance and protective measures. Schools and caregivers should be informed about the condition to ensure a safe environment.
• Regular follow-ups: Schedule regular appointments with a dermatologist and ophthalmologist to monitor for early signs of skin cancer or eye damage.
• Community support: Connect with support groups, such as the XP Family Support Group, for resources, advice, and emotional support.

Emergency Warning Signs

While Xeroderma Pigmentosum itself is a chronic condition, certain symptoms require immediate medical attention. Seek emergency care if you or your child experience any of the following:

• Severe, blistering sunburns: Especially if accompanied by fever, chills, or signs of infection (e.g., pus, increased pain, redness).
• Rapidly growing or changing skin lesions: Any new growth, sore, or mole that changes in size, shape, color, or texture could indicate aggressive skin cancer.
• Eye pain or sudden vision changes: Severe pain, sudden vision loss, or signs of infection (e.g., discharge, extreme redness) require urgent evaluation by an ophthalmologist.
• Signs of neurological decline: Sudden seizures, loss of motor function, or severe headaches could indicate neurological complications.
• Signs of infection: Skin infections (e.g., cellulitis) or systemic infections (e.g., fever, fatigue, confusion) in individuals with XP can be serious due to their increased vulnerability.
• Severe dehydration or heat exhaustion: Due to the need to avoid sun exposure, individuals with XP may be at risk for heat-related illnesses if they overheat while wearing protective clothing.

If any of these emergency signs occur, go to the nearest emergency room or call emergency services immediately. Early intervention can prevent serious complications and improve outcomes.

Reviewed and updated: August 2023 | Sources: Mayo Clinic, NIH, WHO, Cleveland Clinic, American Academy of Dermatology